BIOVENTIX PLC
Develops high-affinity sheep monoclonal antibodies for global clinical diagnostic immunoassays.
BVXP | IL
Overview
Corporate Details
- ISIN(s):
- GB00B4QVDF07
- LEI:
- 213800225MHX7LZQY108
- Country:
- United Kingdom
- Address:
- 7 ROMANS BUSINESS PARK, GU9 7SX FARNHAM
- Website:
- https://www.bioventix.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Bioventix PLC is a biotechnology company specializing in the development and commercial supply of high-affinity sheep monoclonal antibodies (SMAs). These antibodies are utilized as critical components in clinical diagnostic applications, primarily for automated immunoassays used in blood testing. The company supports healthcare organizations by creating novel SMAs, with a development timeline of approximately nine months from initial immunisation to the delivery of purified antibodies for evaluation. Its product portfolio includes a range of SMAs for the global clinical diagnostics market and ELISA kits designed to monitor exposure to industrial pollutants. The company's antibodies are instrumental in various diagnostic areas, including troponin assays for assessing cardiac conditions and research into neurological disorders like Alzheimer's disease.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-13 15:19 |
Major Shareholding Notification
Holding(s) in Company
|
English | 22.0 KB | ||
| 2025-04-28 18:13 |
Director's Dealing
Director Dealing
|
English | 19.8 KB | ||
| 2025-03-31 08:00 |
Interim Report
Interim Results
|
English | 106.1 KB | ||
| 2024-12-24 10:14 |
Director's Dealing
Director Dealing
|
English | 19.3 KB | ||
| 2024-12-06 08:00 |
Post-Annual General Meeting Information
Result of AGM
|
English | 8.1 KB | ||
| 2024-12-04 16:34 |
Major Shareholding Notification
Holding(s) in Company
|
English | 52.9 KB | ||
| 2024-11-22 16:56 |
Director's Dealing
Director/PDMR Shareholding
|
English | 19.5 KB | ||
| 2024-11-08 08:57 |
Report Publication Announcement
Notice of AGM
|
English | 8.1 KB | ||
| 2024-10-31 08:00 |
Director's Dealing
Director/PDMR Shareholding
|
English | 19.2 KB | ||
| 2024-10-28 08:00 |
Annual / Quarterly Financial Statement
Results for the year ended 30 June 2024
|
English | 442.9 KB | ||
| 2024-10-25 11:37 |
Major Shareholding Notification
Holding(s) in Company
|
English | 31.1 KB | ||
| 2024-10-16 14:51 |
Major Shareholding Notification
Holding(s) in Company
|
English | 43.9 KB | ||
| 2024-04-30 08:00 |
Director's Dealing
Director/PDMR Shareholding
|
English | 19.2 KB | ||
| 2024-04-12 12:05 |
Major Shareholding Notification
Holding(s) in Company
|
English | 53.7 KB | ||
| 2024-03-25 08:00 |
Interim Report
Interim Results
|
English | 144.5 KB |
Automate Your Workflow. Get a real-time feed of all BIOVENTIX PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for BIOVENTIX PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
